China Enlists Commercial Insurers in Bid to Boost Local Biotechs

China wants commercial insurance firms to invest in the development of homegrown medicines, Beijing’s latest bid to support its burgeoning biotech and pharmaceutical sector. Commercial insurers have been encouraged to set up investment funds to provide long-term financing and “patience …